And here I was thinking that PoS and co were simply outlining...

And here I was thinking that PoS and co were simply outlining figures to quantify what marketcap Mastitis alone would support, not whether it could support the cost of all the programs POH currently has going.

And you wonder why someone would question your objectivity.

Dhukka you are just trying to complicate this, god knows why. Simply put, if POHs sole product was Mastitis and we worked on a 10% penetration, and gauged rough reveues and costs associated with JUST Mastitis, and a PE of 20, what marketcap could this support.

But you didn't gauge rough revenues and expenses, you took rough revenues. included no expenses and then applied an earnings multiple to revenues. This is amateur hour stuff, it is not valid or even remotely accurate.